Huda H. Al‐Khalaf
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Epidemiology
- Physiology
- Co-authors
- Abdelilah AboussekhraMai AlmohannaSiti‐Faujiah HendrayaniFalah AlmohannaHazem GhebehShreeram C. NallarDhananjaya V. KalvakolanuWedad Saeed Al-Qahtani
- Topics
- Cancer-related Molecular Pathways (13 papers)Epigenetics and DNA Methylation (6 papers)RNA modifications and cancer (6 papers)
- Partner nations
- Saudi ArabiaUnited StatesCanada
In The Last Decade
Huda H. Al‐Khalaf
29 papers receiving 844 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 457
- Oncology 353
- Cancer Research 223
- Epidemiology 88
- Physiology 86
Countries citing papers authored by Huda H. Al‐Khalaf
This map shows the geographic impact of Huda H. Al‐Khalaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huda H. Al‐Khalaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huda H. Al‐Khalaf more than expected).
Fields of papers citing papers by Huda H. Al‐Khalaf
This network shows the impact of papers produced by Huda H. Al‐Khalaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huda H. Al‐Khalaf. The network helps show where Huda H. Al‐Khalaf may publish in the future.
Co-authorship network of co-authors of Huda H. Al‐Khalaf
This figure shows the co-authorship network connecting the top 25 collaborators of Huda H. Al‐Khalaf. A scholar is included among the top collaborators of Huda H. Al‐Khalaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huda H. Al‐Khalaf. Huda H. Al‐Khalaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 103 | |
| 4 | 32 | |
| 5 | 22 | |
| 6 | 22 | |
| 7 | 22 | |
| 8 | 49 | |
| 9 | 53 | |
| 10 | 67 | |
| 11 | 30 | |
| 12 | 32 | |
| 13 | 79 | |
| 14 | 14 | |
| 15 | 13 | |
| 16 | 13 | |
| 17 | 19 | |
| 18 | 17 | |
| 19 | 67 | |
| 20 | 16 |
About Huda H. Al‐Khalaf
Huda H. Al‐Khalaf is a scholar working on Oncology, Aging and Cancer Research, having authored 30 papers that have together received 850 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (13 papers), Epigenetics and DNA Methylation (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (223 citations), Oncology (353 citations) and Molecular Medicine (53 citations). Huda H. Al‐Khalaf has collaborated with scholars based in Saudi Arabia, United States and Canada. Frequent co-authors include Abdelilah Aboussekhra, Mai Almohanna, Siti‐Faujiah Hendrayani, Falah Almohanna, Hazem Ghebeh, Shreeram C. Nallar, Dhananjaya V. Kalvakolanu, Wedad Saeed Al-Qahtani, Abdelbaset Mohamed Elasbali and Bassam Ahmed Almutlaq. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.